The only preclinical imaging platform allowing for fast in vivo screening of SPECT and alpha-emitting isotope radiopharmaceuticals

Now available in High Throughput configuration
The γ-eye™ system is now offered in a High Throughput version, designed to accelerate your research workflow without compromising performance.
- Expanded Field-of-View with 100 mm x 200 mm active area
- Real-time in vivo imaging of up to 4 mice or 1 rat
- All key characteristics of the standard γ-eye™ are fully preserved
- Enhanced performance for faster data acquisition and higher experimental throughput
- Perform more than 110 mouse scans per day, maximizing productivity for time-sensitive or large-cohort studies

Features
- Small animal, SPECT and alpha-emitting isotope live imaging platform
- Optimised to meet the unique imaging challenges of alpha emitter radiotracers
- Detects and resolves the separation of daughter isotopes post alpha decay
- Real time, whole body imaging since time zero post injection, enables fast screening of radiolabeled compounds
- User interchangeable collimators for optimizing parameters on a wide range of applications

Technical Specifications
- State-of-the-art detector characteristics
- <2mm spatial resolution
- Down to 1 sec frames for whole body scans
- Energy resolution down to 11%
- Detectable energy range 35-440 keV
- Weight less than 50kg
- Dimensions: 43cm (L) x 46cm (W) x 43cm (H)
- Compatible with 3rd party anesthesia and Vital Signs monitoring system

Definition of a user friendly platform
- Straightforward workflow with easy imaging protocol set-up
- Plain to operate by non highly-experienced professionals
- Footprint allowing for simple system installation and transfer
- Ideal for imaging inside a clean room, or next to a cyclotron
- Visual | eyes™ software hub for post processing of imaging data
Applications
Oncology, alpha-emitters
Preclinical imaging of theranostics
²²⁵Ac-labelled FAPI-targeting agent on a HEK-FAP mouse model
Images info: 24h post injection – 20min scan – injected activity 0.19MBqApplications
Oncology
Preclinical imaging of a theranostic pair
Tumor imaging with ²⁰³Pb - ²¹²Pb (PSC-PEG-T compound)
Images info: 24h post injection – 10min scan with 30sec frames - injected activity 0.89MBq & 0.02MBq accordinglyApplications
Bone imaging
Imaging the path of theranostics
Free ¹⁷⁷Lu accumulation in the bones of a healthy mouse
Image info: 24h post injection - 20min scan - injected activity 20MBqApplications
Oncology
Preclinical imaging of diagnostic agents
Assessing the efficacy of ¹¹¹In-DOTATATE in targeting tumors, with and without the use of tumor protection.
Images info: 3h post injection - 6min scan - injected activity 4MBq
Publications
- Harnessing LDLR-targeted radiolabeled peptide for imaging in pancreatic adenocarcinoma (PDAC)Read More
- Photoradiolabeling of onartuzumab with ⁹⁹ᵐTc and ¹⁸⁸Re-tricarbonyl for radiotheranostics of gastric cancerRead More
- Synthesis and Characterization of PEG-b-1-Vinyl Imidazole Diblock Copolymers and Their Preliminary Evaluation for Biomedical ApplicationsRead More